Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
May 01, 2026
TickeronGET DAILY SIGNALS
LyondellBasell (LYB) Q1 2026 Earnings Preview: Seeking Signs of Stabilization

LyondellBasell (LYB) Q1 2026 Earnings Preview: Seeking Signs of Stabilization

Key Takeaways

  • Analysts expect LYB to report first-quarter 2026 EPS of about $0.28-$0.31, a rebound from Q4 2025's loss of $0.26 per share.
  • Revenue consensus stands at approximately $7.37 billion, down slightly year-over-year due to softer chemical pricing.
  • Key focus on Olefins & Polyolefins (O&P) segment margins amid global oversupply and weak demand.
  • Company's cash improvement plan targets $1.3 billion by end-2026, supporting dividend stability.
  • Trailing earnings surprises average negative 63.8%, raising bar for positive reaction.
  • EBITDA (earnings before interest, taxes, depreciation, and amortization) expectations hinge on cost controls and volume stability.

Why LYB's Q1 2026 Earnings Matter

LyondellBasell Industries, one of the world's leading chemicals producers, is approaching its first-quarter 2026 earnings report at a critical juncture. Following a full-year 2025 net loss of $738 million—largely due to compressed margins and petrochemical oversupply—investors are looking for evidence of a turnaround. The company's diversified operations across O&P, Advanced Polymer Solutions, and refining give it potential exposure to recovering demand in packaging and durable goods. In my view, this report carries weight because it could highlight progress on the $1.3 billion cash improvement plan, shaping sentiment in an industry strained by overcapacity and economic headwinds. Positive outcomes here might reinforce LYB's appeal through its attractive dividend yield for income-focused investors.

Consensus Expectations for the Quarter

Wall Street forecasts point to Q1 2026 revenue of $7.37 billion for LyondellBasell, a slight dip from $7.677 billion in the prior-year quarter, mainly from lower average selling prices even as volumes hold steady. The consensus EPS estimate sits at $0.28, drawn from 15 analysts—a marked improvement over Q4 2025's $0.26 loss per share, though still trailing Q1 2025's $0.33 excluding identified items.

One area I'll be watching closely is EBITDA, projected in the $500-600 million range when adjusting historical trends for today's environment, along with segment breakdowns. Margins in the O&P segment will draw particular scrutiny given the ethylene and propylene glut. Updates on 2026 capex around $1.2 billion and ongoing cost savings will also matter. LYB has a recent track record of missing EPS targets, as seen in Q4 2025's -$0.26 actual versus $0.22 expected, yet the stock climbed afterward on hopes of recovery. Post-earnings moves have typically been volatile, often +5-10% on beats.

Market Sentiment Heading In

Sentiment toward LYB remains cautiously optimistic ahead of this release, with the Earnings Surprise Prediction (ESP) metric at +10.28% hinting at a possible beat. The shares demonstrated resilience after Q4's miss, supported by expectations around cost reductions. That said, risks linger from softer demand in Europe and China, as well as fluctuating energy costs. Options activity suggests an 8-10% swing post-earnings, consistent with past patterns. With peers in the chemicals sector under similar strain, much attention will fall on LYB's guidance.

Leveraging Tickeron’s AI Screener in My Analysis

In my research process, I often turn to Tickeron’s AI Screener, an AI-driven tool that lets me sift through stocks and ETFs using technical patterns, fundamentals, trends, volatility, and predictive signals. It scans thousands of names with filters for industry peers, market cap, indicators, price patterns, and metrics, surfacing ideas like breakout candidates or value plays far quicker than manual methods. For instance, I used it here to gauge how LYB stacks up against chemical sector peers—it's a straightforward way to spot relative opportunities and refine my outlook.

Looking Ahead: Key Factors to Track

Once the numbers are out, management's take on 2026 demand trends will take center stage. Petrochemical oversupply looks set to linger through mid-year, though potential supply disruptions might widen O&P spreads. Demand for oxyfuels, linked to refining operations, continues as a positive amid stable gasoline use.

Progress on the $1.3 billion cash generation target by year-end remains crucial, covering $1.2 billion in capex while sustaining the adjusted dividend. I'll also monitor margin gains in Intermediates & Derivatives from disciplined cost management.

On the bigger picture, advancements in U.S. Gulf Coast projects and sustainability efforts could provide tailwinds amid evolving regulations. Industry-wide chemical production growth of 1-3% supports the case, but global economic signals around packaging and construction will be telling. Strong execution on these fronts could set LYB up for better full-year results.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LYB

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


LYB's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for LYB turned positive on October 08, 2026. Looking at past instances where LYB's MACD turned positive, the stock continued to rise in 34 of 49 cases over the following month. The odds of a continued upward trend are 69%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on LYB as a result. In 64 of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.

LYB moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for LYB crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.

Following a +1.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where LYB advanced for three days, in 184 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

The Aroon Indicator entered an Uptrend today. In 135 of 203 cases where LYB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 67%.

Bearish Trend Analysis

The 10-day RSI Indicator for LYB moved out of overbought territory on November 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 21 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 72%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for LYB moved below the 200-day moving average on October 28, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LYB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.

LYB broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 28 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.025) is normal, around the industry mean (2.436). P/E Ratio (-59.714) is within average values for comparable stocks, (-18.867). Projected Growth (PEG Ratio) (1.526) is also within normal values, averaging (1.548). Dividend Yield (0.041) settles around the average of (0.039) among similar stocks. P/S Ratio (0.670) is also within normal values, averaging (48.960).

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. LYB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LYB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 11.76B. The market cap for tickers in the group ranges from 50 to 239.58B. LIN holds the highest valuation in this group at 239.58B. The lowest valued company is JSCPY at 50.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was -2%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -7%. SNES experienced the highest price growth at 24%, while YMAT experienced the biggest fall at -39%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was 28%. For the same stocks of the Industry, the average monthly volume growth was 25% and the average quarterly volume growth was -36%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 55
Price Growth Rating: 52
SMR Rating: 78
Profit Risk Rating: 81
Seasonality Score: -1 (-100 ... +100)
View a ticker or compare two or three
LYB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of petrochemicals

Industry ChemicalsSpecialty

Industry
Chemicals Specialty
Address
One Vine Street
Phone
+44 2072202600
Employees
18970
Web
https://www.lyondellbasell.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of approximately $8.5 billion, a roughly 5% increase from $8.1 billion in Q1 2025. Consensus adjusted earnings per share (EPS) forecast stands at $4.74, reflecting a potential decline from prior-year levels amid pricing pressures.
Analysts expect Q1 2026 adjusted EPS of around $1.61, down from prior year levels due to softer commodity prices. Consensus revenue forecast stands at approximately $14.5 billion, reflecting a year-over-year decline.